Erratum: ERRATUM: OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer (Ann Oncol (2019) DOI: 10.1093/annonc/mdy522)

T. Y. Seiwert, C. C. Foster, E. A. Blair, T. G. Karrison, Nishant Agrawal, J. M. Melotek, L. Portugal, R. J. Brisson, A. Dekker, S. Kochanny, Z. Gooi, M. W. Lingen, V. M. Villaflor, D. T. Ginat, D. J. Haraf, E. E. Vokes

Research output: Contribution to journal › Comment/debate › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: ERRATUM: OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer (Ann Oncol (2019) DOI: 10.1093/annonc/mdy522)'. Together they form a unique fingerprint.

Medicine & Life Sciences